Literature DB >> 7718082

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

S Grabbe1, S Beissert, T Schwarz, R D Granstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7718082     DOI： 10.1016/0167-5699(95)80125-1

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  26 in total

1.  Deregulated cytokine network and defective Th1 immune response in multiple myeloma.

Authors:  M A Frassanito; A Cusmai; F Dammacco
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro.

Authors:  C J Kim; T Prevette; J Cormier; W Overwijk; M Roden; N P Restifo; S A Rosenberg; F M Marincola
Journal:  J Immunother       Date:  1997-07       Impact factor: 4.456

Review 3.  Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.

Authors:  R G Vile; H Chong
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 4.  Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer.

Authors:  M T Lotze
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

5.  Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.

Authors:  N Seo; Y Tokura; T Nishijima; H Hashizume; F Furukawa; M Takigawa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 6.  Granulocyte-macrophage colony-stimulating factor and the immune system.

Authors:  P E Tarr
Journal:  Med Oncol       Date:  1996-09       Impact factor: 3.064

Review 7.  Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.

Authors:  Pierpaolo Correale; Maria Grazia Cusi; Lucia Micheli; Cristina Nencini; Maria Teresa Del Vecchio; Francesco Torino; Angelo Aquino; Enzo Bonmassar; Guido Francini; Giorgio Giorgi
Journal:  Invest New Drugs       Date:  2006-03       Impact factor: 3.850

8.  Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors.

Authors:  K Ohishi; N Katayama; H Mitani; H Araki; M Masuya; H Suzuki; N Hoshino; H Miyashita; K Nishii; S Kageyama; N Minami; H Shiku
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

9.  Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Authors:  S Hong; H Li; J Qian; J Yang; Y Lu; Q Yi
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

10.  Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma.

Authors:  Gwang-Seong Choi; Moon-Hee Lee; Soon-Ki Kim; Chul-Soo Kim; Hong-Sik Lee; Moon-Whan Im; Hye-Yun Kil; Do-Hwan Seong; Jong-Rok Lee; Woo-Chul Kim; Min-Geol Lee; Sun U Song
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.